Acceleron Pharma
XLRN
#1580
Rank
NZ$19.02 B
Marketcap
$311.06
Share price
0.00%
Change (1 day)
16,269.99%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$19.02 Billion

As of December 2024 Acceleron Pharma has a market cap of NZ$19.02 Billion. This makes Acceleron Pharma the world's 1580th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$248.77 B 1,207.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$141.51 B 643.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$613.41 B 3,124.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$36.37 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.02 B-94.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.62 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$260.64 B 1,270.14%๐Ÿ‡บ๐Ÿ‡ธ USA